Elekta AB (publ) (EKTA-B) - Net Assets

Latest as of October 2025: Skr8.49 Billion SEK

Based on the latest financial reports, Elekta AB (publ) (EKTA-B) has net assets worth Skr8.49 Billion SEK as of October 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr28.24 Billion) and total liabilities (Skr19.74 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr8.49 Billion
% of Total Assets	30.08%
Annual Growth Rate	8.78%
5-Year Change	7.97%
10-Year Change	37.99%
Growth Volatility	12.4

Elekta AB (publ) - Net Assets Trend (2002–2025)

This chart illustrates how Elekta AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Elekta AB (publ) (2002–2025)

The table below shows the annual net assets of Elekta AB (publ) from 2002 to 2025.

Year	Net Assets	Change
2025-04-30	Skr8.85 Billion	-17.92%
2024-04-30	Skr10.78 Billion	+10.76%
2023-04-30	Skr9.73 Billion	+9.18%
2022-04-30	Skr8.91 Billion	+8.79%
2021-04-30	Skr8.20 Billion	+1.01%
2020-04-30	Skr8.11 Billion	+4.29%
2019-04-30	Skr7.78 Billion	-2.47%
2018-04-30	Skr7.98 Billion	+17.73%
2017-04-30	Skr6.78 Billion	+5.66%
2016-04-30	Skr6.41 Billion	-3.51%
2015-04-30	Skr6.64 Billion	+6.20%
2014-04-30	Skr6.26 Billion	+12.54%
2013-04-30	Skr5.56 Billion	+10.98%
2012-04-30	Skr5.01 Billion	+30.71%
2011-04-30	Skr3.83 Billion	+18.16%
2010-04-30	Skr3.24 Billion	+26.97%
2009-04-30	Skr2.56 Billion	+40.23%
2008-04-30	Skr1.82 Billion	-2.20%
2007-04-30	Skr1.86 Billion	-0.27%
2006-04-30	Skr1.87 Billion	+10.27%
2005-04-30	Skr1.69 Billion	+19.89%
2004-04-30	Skr1.41 Billion	-2.21%
2003-04-30	Skr1.45 Billion	+13.07%
2002-04-30	Skr1.28 Billion	--

Equity Component Analysis

This analysis shows how different components contribute to Elekta AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 4482.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (April 2025)

Component	Amount	Percentage
Retained Earnings	Skr6.64 Billion	75.49%
Common Stock	Skr192.00 Million	2.18%
Other Comprehensive Income	Skr1.15 Billion	13.11%
Other Components	Skr812.00 Million	9.22%
Total Equity	Skr8.80 Billion	100.00%

Elekta AB (publ) Competitors by Market Cap

The table below lists competitors of Elekta AB (publ) ranked by their market capitalization.

Company	Market Cap
ARIS MNG.CORP. F:ZP1	$2.30 Billion
Mister Car Wash, Inc. Common Stock NASDAQ:MCW	$2.30 Billion
Krungthai Card Public Company Limited BK:KTC-R	$2.30 Billion
The Andersons Inc NASDAQ:ANDE	$2.30 Billion
Foot Locker Inc NYSE:FL	$2.29 Billion
Hunan Zhongke Electric SHE:300035	$2.29 Billion
Compania Cervecerias Unidas SA SN:CCU	$2.29 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	$2.29 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Elekta AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 10,775,000,000 to 8,803,000,000, a change of -1,972,000,000 (-18.3%).
Net income of 237,000,000 contributed positively to equity growth.
Dividend payments of 917,000,000 reduced retained earnings.
Other comprehensive income decreased equity by 1,306,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr237.00 Million	+2.69%
Dividends Paid	Skr917.00 Million	-10.42%
Other Comprehensive Income	Skr-1.31 Billion	-14.84%
Other Changes	Skr14.00 Million	+0.16%
Total Change	Skr-	-18.30%

Book Value vs Market Value Analysis

This analysis compares Elekta AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.52x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 17.90x to 2.52x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2002-04-30	Skr3.25	Skr58.10	x
2003-04-30	Skr3.68	Skr58.10	x
2004-04-30	Skr3.61	Skr58.10	x
2005-04-30	Skr4.50	Skr58.10	x
2006-04-30	Skr4.93	Skr58.10	x
2007-04-30	Skr4.93	Skr58.10	x
2008-04-30	Skr4.88	Skr58.10	x
2009-04-30	Skr6.91	Skr58.10	x
2010-04-30	Skr8.72	Skr58.10	x
2011-04-30	Skr10.14	Skr58.10	x
2012-04-30	Skr13.15	Skr58.10	x
2013-04-30	Skr14.57	Skr58.10	x
2014-04-30	Skr15.60	Skr58.10	x
2015-04-30	Skr17.41	Skr58.10	x
2016-04-30	Skr16.79	Skr58.10	x
2017-04-30	Skr17.77	Skr58.10	x
2018-04-30	Skr20.88	Skr58.10	x
2019-04-30	Skr20.36	Skr58.10	x
2020-04-30	Skr21.23	Skr58.10	x
2021-04-30	Skr21.45	Skr58.10	x
2022-04-30	Skr23.32	Skr58.10	x
2023-04-30	Skr25.44	Skr58.10	x
2024-04-30	Skr28.20	Skr58.10	x
2025-04-30	Skr23.04	Skr58.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Elekta AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.69%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 1.32%
• Asset Turnover: 0.62x
• Equity Multiplier: 3.29x
Recent ROE (2.69%) is below the historical average (15.26%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	11.45%	5.30%	1.08x	2.00x	Skr18.40 Million
2003	16.19%	8.41%	0.94x	2.05x	Skr89.50 Million
2004	17.55%	8.55%	0.94x	2.18x	Skr106.70 Million
2005	14.94%	8.03%	0.70x	2.66x	Skr83.60 Million
2006	16.27%	6.88%	0.84x	2.83x	Skr117.20 Million
2007	18.74%	7.69%	0.84x	2.88x	Skr162.30 Million
2008	22.51%	7.99%	0.80x	3.50x	Skr225.60 Million
2009	21.47%	8.16%	0.84x	3.13x	Skr291.70 Million
2010	25.69%	11.27%	0.87x	2.63x	Skr508.70 Million
2011	26.91%	13.04%	0.88x	2.34x	Skr647.80 Million
2012	24.54%	13.56%	0.59x	3.05x	Skr727.10 Million
2013	24.16%	12.96%	0.63x	2.94x	Skr785.30 Million
2014	18.37%	10.73%	0.60x	2.86x	Skr523.10 Million
2015	8.32%	5.09%	0.51x	3.19x	Skr-111.70 Million
2016	2.14%	1.22%	0.58x	3.04x	Skr-503.20 Million
2017	1.85%	1.17%	0.51x	3.09x	Skr-552.50 Million
2018	13.78%	9.70%	0.50x	2.82x	Skr301.40 Million
2019	15.40%	8.84%	0.56x	3.09x	Skr420.20 Million
2020	13.36%	7.42%	0.51x	3.50x	Skr272.80 Million
2021	15.30%	9.11%	0.55x	3.03x	Skr434.50 Million
2022	12.95%	7.93%	0.55x	2.95x	Skr262.80 Million
2023	9.69%	5.59%	0.57x	3.04x	Skr-29.90 Million
2024	12.08%	7.19%	0.58x	2.92x	Skr224.50 Million
2025	2.69%	1.32%	0.62x	3.29x	Skr-643.30 Million

Industry Comparison

This section compares Elekta AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $771,220,093
Average return on equity (ROE) among peers: -10.86%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Elekta AB (publ) (EKTA-B)	Skr8.49 Billion	11.45%	2.33x	$2.30 Billion
Acarix A/S (ACARIX)	$100.54 Million	-51.52%	0.18x	$37.60 Million
Arcoma AB (ARCOMA)	$45.19 Million	14.63%	0.84x	$12.97 Million
Bactiguard Holding AB (publ) (BACTI-B)	$140.95 Million	-2.42%	4.09x	$57.80 Million
BICO Group AB (BICO)	$6.93 Billion	-12.06%	0.47x	$149.79 Million
Boule Diagnostics AB (BOUL)	$229.76 Million	15.68%	0.59x	$15.92 Million
CellaVision AB (CEVI)	$20.07 Million	13.08%	1.20x	$414.80 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$10.36 Million	-48.01%	0.14x	$15.81 Million
Chordate Medical Holding AB (CMH)	$35.72 Million	-45.19%	0.33x	$29.05K
C-Rad AB (publ) (CRAD-B)	$199.79 Million	7.19%	0.35x	$95.07 Million
Duearity AB (DEAR)	$-2.39 Million	0.00%	0.00x	$331.97K

About Elekta AB (publ)

ST:EKTA-B Sweden Medical Devices

Market Cap

$2.30 Billion

Skr21.33 Billion SEK

Market Cap Rank

#5830 Global

#69 in Sweden

Share Price

Skr58.10

Change (1 day)

+2.11%

52-Week Range

Skr40.64 - Skr63.25

All Time High

Skr125.13